FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

372538008: Irinotecan (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1197831015 Irinotecan (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1211071010 Irinotecan en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan Is a Substance with topoisomerase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Irinotecan Is a Allergen class false Inferred relationship Existential restriction modifier
Irinotecan Is a Drug allergen false Inferred relationship Existential restriction modifier
Irinotecan Has disposition Topoisomerase inhibitor true Inferred relationship Existential restriction modifier
Irinotecan Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Irinotecan Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Irinotecan Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Irinotecan Is a Carboxylic ester true Inferred relationship Existential restriction modifier
Irinotecan Is a Piperidine true Inferred relationship Existential restriction modifier
Irinotecan Is a Carbamic acid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing irinotecan Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier 1
Irinotecan hydrochloride Is a False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan hydrochloride Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Camptosar 20mg/ml injection 5mL vial Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Product containing irinotecan in parenteral dose form (medicinal product form) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier 1
Irinotecan liposome Is a False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan hydrochloride Is modification of True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan liposome Is modification of True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate Is modification of False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier 1
Product containing only irinotecan in parenteral dose form (medicinal product form) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier 1
Folinic acid, fluorouracil and irinotecan antineoplastic chemotherapy regimen Direct substance True Irinotecan Inferred relationship Existential restriction modifier 1
Fluorouracil, leucovorin, irinotecan and oxaliplatin antineoplastic chemotherapy regimen Direct substance True Irinotecan Inferred relationship Existential restriction modifier 1
Irinotecan sucrosofate Is modification of True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate Is a False Irinotecan Inferred relationship Existential restriction modifier
Campto 100mg/5ml solution for injection vials (Pfizer Ltd) Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Campto 40mg/2ml solution for injection vials (Pfizer Ltd) Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Irinotecan Inferred relationship Existential restriction modifier
Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Irinotecan Inferred relationship Existential restriction modifier
Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml solution for injection vials 1 vial Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Campto 100mg/5ml solution for injection vials (Pfizer Ltd) 1 vial Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Campto 40mg/2ml solution for injection vials (Pfizer Ltd) 1 vial Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml solution for infusion vials Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml solution for infusion vials Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Actavis UK Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (medac UK) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Hospira UK Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Accord Healthcare Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vial (Accord Healthcare Ltd) (product) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 200mg/250ml in Sodium chloride 0.9% infusion bags Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 240mg/250ml in Sodium chloride 0.9% infusion bags Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 260mg/250ml in Sodium chloride 0.9% infusion bags Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 200mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 240mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 260mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 280mg/250ml in Sodium chloride 0.9% infusion bags Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 300mg/250ml in Sodium chloride 0.9% infusion bags Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 320mg/250ml in Sodium chloride 0.9% infusion bags Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 280mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 300mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 320mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 360mg/250ml in Sodium chloride 0.9% infusion bags Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 400mg/250ml in Sodium chloride 0.9% infusion bags Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 360mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 400mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for infusion vials Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml solution for infusion vials Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Accord Healthcare Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Accord Healthcare Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Accord Healthcare Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml solution for infusion vials Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for infusion vials Has active ingredient False Irinotecan Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) Has active ingredient True Irinotecan Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start